Mainz Biomed BV Cash Flow-to-Debt Ratio
Mainz Biomed BV cash flow-to-debt ratio. Mainz Biomed BV (MYNZ) has a Cash Flow-to-Debt Ratio of -0.95x as of December 2025, meaning its operating cash flow of $-4.46 Million could theoretically repay -1% of its total liabilities ($4.69 Million) in one year. See MYNZ financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Mainz Biomed BV (2019–2025)
Cash flow-to-debt ratio of Mainz Biomed BV from 2019 to 2025. Historical debt coverage capacity for Mainz Biomed BV across 7 annual periods. Also explore Mainz Biomed BV annual equity growth to track the company's year-over-year net asset growth rate.
Mainz Biomed BV Cash Flow-to-Debt Ratio by Year (2019–2025)
Mainz Biomed BV cash flow-to-debt ratio by year from 2019 to 2025. Year-by-year debt coverage analysis for Mainz Biomed BV. For the full cash flow conversion analysis, see Mainz Biomed BV cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.34x | $-10.98 Million | $4.69 Million | ▲ +1.4% |
| 2024 | -2.38x | $-17.09 Million | $7.19 Million | ▼ -31.7% |
| 2023 | -1.80x | $-21.94 Million | $12.16 Million | ▲ +24.9% |
| 2022 | -2.40x | $-14.77 Million | $6.14 Million | ▼ -174.6% |
| 2021 | -0.88x | $-3.22 Million | $3.68 Million | ▼ -537.6% |
| 2020 | -0.14x | $-468.74K | $3.41 Million | ▲ +12.1% |
| 2019 | -0.16x | $-416.50K | $2.67 Million | — |